Weighted Average Number of Shares Outstanding, Diluted of BioCorRx Inc. from Q3 2011 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
BioCorRx Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q3 2011 to Q3 2025.
  • BioCorRx Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 18.2M shares, a 66.5% increase year-over-year.
  • BioCorRx Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 3.38M shares, a 25.3% increase from 2023.
  • BioCorRx Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.7M shares, a 86.3% increase from 2022.
  • BioCorRx Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.45M shares, a 37.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

BioCorRx Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 18.2M +7.25M +66.5% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q1 2025 3.55M +611K +20.8% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q3 2024 10.9M 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q1 2024 2.94M +1.14M +63.5% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q1 2023 1.8M +727K +67.8% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q1 2022 1.07M -59.1K -5.22% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q1 2021 1.13M -4.17K -0.37% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q1 2020 1.14M -1.29M -53.2% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q1 2019 2.43M +624K +34.6% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q2 2018 250M -329M -56.8% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 1.8M -354M -99.5% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q2 2017 580M 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 356M +330M +1294% 01 Jan 2017 31 Mar 2017 10-Q 18 May 2018
Q1 2016 25.5M +5.73M +28.9% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q2 2015 152M +9.76M +6.87% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2015
Q1 2015 19.8M -775K -3.76% 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016
Q2 2014 142M +25.4M +21.8% 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015
Q1 2014 20.6M 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q2 2013 117M 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q3 2012 101M +63.9M +173% 01 Jul 2012 30 Sep 2012 10-Q 19 Nov 2012
Q3 2011 37M 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012

BioCorRx Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 3.38M +681K +25.3% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 2.7M +1.25M +86.3% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 1.45M +393K +37.2% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 1.06M -85.8K -7.52% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 1.14M +5.83K +0.51% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 1.14M -1.29M -53.3% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 2.43M +614K +33.8% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 1.82M -248M -99.3% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019
2016 250M +223M +834% 01 Jan 2016 31 Dec 2016 10-K 05 Apr 2018
2015 26.8M +8.81M +49% 01 Jan 2015 31 Dec 2015 10-K 13 Apr 2017
2014 18M +2.18M +13.8% 01 Jan 2014 31 Dec 2014 10-K 14 Apr 2016
2013 15.8M -90.4M -85.1% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 106M +55.6M +110% 01 Jan 2012 31 Dec 2012 10-K 14 Apr 2014
2011 50.6M 01 Jan 2011 31 Dec 2011 10-K 15 Apr 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.